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Abstract
Background Patient participation in study design is paramount to
design studies that are acceptable to patients. Despite an increase in
research involving pregnant women, relatively little is known about
the motivational factors that govern their decision to be involved in
a clinical trial, compared to other patient groups.
Objective To better understand the viewpoints of pregnant women
who take part in clinical trials.
Method We chose to use Q-Methodology, a method of exploring
the structure of opinions surrounding a topic. We developed a set
of 40 statements that encompassed the reasons why pregnant
women might want to take part in research and 30 research partic-
ipants from the PRiDE study (an observational trial investigating
the role of micronutrients in gestational diabetes) were asked to
rank them in order of agreement. The ﬁnished matrices from each
participant were compared and analysed to produce capturing
viewpoints.
Results About 30 women aged 19–40 involved in the PRiDE study
completed the questionnaire. There were two overarching motiva-
tors that emerged: a willingness to help medical research and
improve our knowledge of medical science, and having a personal
connection to the disease, therefore a potential fear of being aﬀected
by it. A third, less signiﬁcant viewpoint, was that of a lack of incon-
venience being a motivating factor.
Conclusion and discussion Understanding what motivates pregnant
women to decide to take part in a research study is valuable and
helps researchers maximize their uptake and retention rates when
designing a trial involving pregnant women.
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Background
Historically, women of childbearing age have
been excluded from trials due to concerns over
foetal safety. There has been a relative lack of
therapeutic trials involving pregnant women.
This had led to a deﬁciency in knowledge of the
safety of many medicinal products in pregnancy
and in children and the prescription of unlicensed
medicines whereby the prescriber takes responsi-
bility for non-intended side-eﬀects. In 1993, the
FDA lifted its ban of the testing of medicinal
products on women1 and the National Institute
of Health made it a legal requirement to include
women in trials.2,3 The Royal College of Physi-
cians followed suit in 2007 and published
guidelines on how to safely involve women.4 Due
to these changes in policy, we can expect that
research involving pregnant women will be
increasing, and yet little is known about why this
specialist group would choose to take part.
A literature review of reasons why patients
agree to take part in trials revealed a large num-
ber of studies investigating cancer patients and a
smaller number investigating specialist groups
including cardiac failure patients, elderly
patients, low-income groups and African Ameri-
cans as specialist populations. There were few
investigating pregnant women, a unique group
of patients whose reasons for participation will
undoubtedly diﬀer from those already studied as
a healthy group who will be paying considera-
tion to their unborn child. We summarize the
ﬁndings of these studies in Table 1.
There were emerging themes of note that were
speciﬁc to pregnant women such as the consider-
ation of the risk to foetus,5,10 as well as potential
beneﬁt.6,8,10,12 A theme across many of the stud-
ies was a perception that being in a trial would
mean superior care to those not participat-
ing.6,7,10,12 Pregnancy could be the ﬁrst time that
women have regular contact with health-care
professionals, so it is understandable that the
attitude of the professionals had a great impact
on the choices the women made.7,8,12 Altruism
played a part in the decision-making process, as
it does with all types of patients considering
entering a clinical trial; women want to help
others, particularly those in a similar situation
to them.6–8,10 There was also a convenience fac-
tor which inﬂuenced the decision-making
process; pregnant women do not have the time
nor energy to take part in trials that require a
great deal of commitment, the easier it is on their
schedules and health the more likely they are to
accept.5–7,9
Qualitative interviewing and closed question-
naires are commonly used to investigate subject
matter relating to patient choice; however, these
have limitations. Interviews are time-consuming
and can cover a broad range of subject matter.
The sample size must therefore be smaller, and
the results are diﬃcult to compare and apply to a
wider population. In contrast, questionnaires are
more practical but are binary in their responses,
and they lose the qualitative reasoning that the
participant would be able to share in an inter-
view. They also require validation by expert
groups, which is a time-consuming process.
Often, people have many reasons to participate in
research and both of these techniques may eluci-
date those reasons, but will not necessarily allow
the participant to add a weighting which tells the
researcher what is most to least important to
them. Q-Methodology addresses these problems.
It is practical and captures the individual and var-
ied views of a reasonable sized group, yet still
allows for comparison in a quantitative manner.
It also allows for the direct comparison by the
participant of reasons to participate in research,
allowing the researcher to place emphasis on
these to design studies ﬁtting for their chosen
group of participants.
We carried out a study of women involved in a
clinical trial investigating the role of micronutri-
ents in the development of gestational diabetes.
To draw particular focus to what motivated the
women to consent, we used Q-Methodology,13
for a systematic mapping of shared viewpoints
on a topic which would not arise from interview-
ing or standard questionnaires alone.
Method
The PRiDE study is a multicentre observational
trial funded by the Medical Research Council
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Table 1 A summary of studies to date
Study Description Findings
Mohanna
et al.5
Semistructured interviews and thematic
analysis of 18 women who had declined
to take part in a prophylactic nifedipine
trial for preterm labour (27% uptake rate)
2 years later
Declined to take part in the trial because:
Protection of the foetus
‘it will never happen to me’
Presence of a placebo arm
Feeling like Guinea pigs
Already ‘felt ill in pregnancy’
Not enough public knowledge of the trial
Rodger
et al.6
50 cross-sectional surveys and
semistructured interviews regarding a
hypothetical trial of low molecular
heparin in pregnancy
Important determining factors:
Potential benefit to foetus (68%)
Personal health (27%)
Altruism (5%)
Pregnant women may be willing to accept risk to
themselves if foetus could benefit.
Baker
et al.7
Focus groups and semistructured
interviews with 17 post-natal women
who had participated in a programme of
maternity care research, followed by
thematic analysis
Factors involved in decision-making
Altruism and self-protection
Enhanced care
Professional guidance
Suitable methodology
Practical inconvenience, an apparent lack of clinical equipoise and
feeling disempowered demotivated women
Kenyon
et al.8
20 qualitative interviews after involvement
in a randomized controlled trial of
antibiotics to prevent preterm labour.
Analysed using constant comparison
Experiences of the recruitment process:
Motivations: better outcome for baby, helping women in the future
in same situation, positive social interaction with consenting
health-care professional and high quality of information given
Acuity of the situation led to perception of poor judgement of risk
and understanding of trial design.
Background presumption of antibiotics being safe.
Nechuta
et al.9
Cross-sectional survey in nine prenatal
clinics of 311 pregnant women about
attitudes to data collection for
epidemiological studies involving their
children
Phone interview preferred to face-to-face interviews
Reluctance to allow access to medical records and infant
examinations in women with post-secondary school education
34–48% would require no compensation for participating.
Lyerly
et al.10
22 semistructured interviews of women in
H1N1 vaccine trial
Motivators:
Women motivated by the media: highlighted the risks of H1N1
infection in pregnancy
Perceived safety advantage
Early access to vaccine
To improve knowledge in the area
Demotivators: risk to foetus, a placebo arm, a change to plan in care
Nechuta
et al.11
311 women interviewed at first prenatal
care visit about attitudes to collection
and storage of biological samples (blood,
placenta, cord blood)
More likely to allow collection of maternal blood (72%) than cord
blood (63%) or placental tissue (64%). 68% agree with storage of
samples. 25–28% would not participate even if compensated,
higher in Hispanic ethnicity and primiparous women
Smyth
et al.12
Semistructured interviews of 16 women
involved in a trial of anticonvulsants in
the prevention of pre-eclampsia
Motivators:
Unpredictability of pre-eclampsia
Quality of information received
Role of health-care professionals and family
Perceived personal benefit
Perception of voluntariness of joining
Studies to date that have investigated why pregnant women take part in clinical trials with descriptions and finding summaries.
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investigating the role of vitamin B12 in the
development of diabetes in pregnancy. Our
study was formally ethically approved as a sub-
study PRiDE. We asked 30 women enrolled in
the PRiDE study at George Eliot Hospital to
take part in this questionnaire during their glu-
cose tolerance test appointment. The inclusion
criteria for the PRiDE study are same as the risk
factors for gestational diabetes: BMI > 30, pre-
viously given birth to a large (>4.5 kg) baby,
previously had gestational diabetes, ﬁrst degree
relative to diabetes, and Asian/Black Caribbean/
Middle Eastern ethnic origin. To participate in
PRiDE, the patient must have at least one risk
factor. Women were asked to take part during
glucose tolerance test clinics on 18 separate days
between 2 September 2013 and 15 January 2014.
All 30 women enrolled in the PRiDE study who
attended clinic on one of the 18 days were asked
to take part during a 2-h waiting period and all
30 accepted.
In Q-Methodology, the participant is asked to
rank items (the Q-set) based on their viewpoint,
following a condition, for example level of agree-
ment. The ﬁnished matrix (the Q-Sort) is
correlated with all other participants, allowing a
derivation of the level of agreement and
disagreement between each participant. Factor
analysis is used to extract intercorrelated
Q-Sorts, which represents participants who have
a similar viewpoint. The analysis is used to pro-
duce an ideal Q-Sort for each viewpoint that is
then named and interpreted.
A Q-Set of 40 statements of why pregnant
women may decide to participate in the PRiDE
study was derived by a literature review and
informal semistructured interviewing. To cap-
ture as wide a range of statements as possible,
the literature review involved all studies explor-
ing motivational factors for involvement in
research, including in non-pregnant participants,
although statements that would not apply to our
population were excluded (i.e. those involving
life-saving therapy and having ‘nothing to lose’
as life expectancy was short). We identiﬁed 105
unique reasons why pregnant patients may
choose to participate in trials. This was supple-
mented with 20 unique reasons which were
derived from informal, semistructured interview-
ing of PRiDE researchers (including doctors,
midwives, nurses and administrators) and
PRiDE participants. The 125 statements were
grouped into emerging themes, and 40 key state-
ments, which best exempliﬁed the themes, were
chosen to include in the Q-Set. This was done so
that participants could work with a manageable
number of items that thoroughly covered a
broad range of opinions and were diﬀerent
enough for the participants to be able to rank.
Figure 1 shows a ﬂow chart of the methodology.
Q-Sorts can be administered in a number of
ways, including paper cards. We chose to use an
iPad that was more user-friendly, allowed the
participant to carry out the ranking in stages
and enabled streamlined data collection and
analysis. The participants were asked to rank the
40 items using an iPad and the Poet-Q plat-
form.14 This allowed them to systematically
choose the statements they agreed with most
from the pool of items to form a ﬁnished Q-Sort.
The participants were then given the opportu-
nity to explain their reasoning for the items they
agreed with most and least. The questionnaire
took an average of 20 min to complete. The
Poet-Q platform15 makes the ranking of state-
ments user-friendly by asking the participants
ﬁrstly to group the statements into ‘agree-most’
and ‘agree-least’ categories, then asks the partici-
pant, in stages, to further delineate between the
statements in each category. The participants
were all able to complete the Q-Sort using
Poet-Q, and the only issues encountered were
Figure 1 A flow chart depicting the process of collecting appropriate statements, asking participants to rank these statements
and analysing the responses.
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with the loss of a wireless connection and with
holding the iPad in the correct orientation.
There was a data collector present in the depart-
ment to resolve these issues. In a Q-Sort, each
statement is given a score depending on its posi-
tion in the matrix. Pearson’s formula is used to
calculate the correlation between each ﬁnished
Q-Sort. A level of signiﬁcance of P < 0.01 is
used to ﬂag up signiﬁcant correlations in a
correlation table. This was done by the PQ
Method program.16
PQ Method highlighted emerging ‘factors’ by
identifying participants who had Q-Sorts with a
high level of correlation. Each participant is
compared against a ‘factor ideal’ to identify how
much their ideas correlate with the standard.
After the identiﬁcation of the ﬁrst factor, the
communality they share is extracted from the
matrix to ﬁnd the second factor. This is done
until there are no more factors left to derive. The
factors were then subjected to a Varimax rota-
tion with the intention to maximize the number
of sorts showing preference for one given factor.
In Q-Methodology, the factors derived equate to
statistically derived, shared viewpoints on the
subject matter at hand. The terms ‘factor’ and
‘viewpoint’ are used interchangeably in the
remainder of this study.
Results
Our population included 30 women from the
PRiDE study who attended their glucose toler-
ance test between 2 September 2013 and 15
January 2014 (Table 2). Ages ranged from 19 to
40, with 60% aged between 21 and 30. The
majority (80%) of our population was Cau-
casian. The women had a variety of occupations,
almost half in the public sector industries
(Health care = 4, Community = 5, Educa-
tion = 4), and more than a quarter were
housewives/unemployed.
A three-factor solution was accepted from
Centroid analysis using PQ Method based on an
explanation variance of 57% and eigenvalues of
14.6, 1.7 and 0.9 for factors 1, 2 and 3, respec-
tively. A ﬁve-, six- and seven-factor solution was
ruled out. A four-factor solution was considered
but ruled out as there was insuﬃcient loading on
the fourth factor. Sorts that were representative
of one factor more than the others (also known
as ‘loading’ on factor) with statistical signiﬁcance
(P < 0.01) were ﬂagged as ‘factor determining
sorts’. The numbers of sorts loading on each fac-
tor 1, 2 and 3 were 6, 9 and 2, respectively: a total
of 17 participants were signiﬁcantly loading on
one of the three factors. Using the sorts that were
loading on each of the three factors, PQ Method
was used to create a factor array: an exemplary
Q-Sort for each factor that showed the ideal posi-
tioning of each of the statements for a participant
with the viewpoint in question. An example of a
factor arrays is shown in Fig. 2. PQ Method was
also used to calculate the correlation between
each of the factors (Table 3) and diﬀerences
between them, and identiﬁed distinguishing and
consensual statements.
Table 4 summaries the high- and low-scoring
statements for each of the derived factors.
Table 5 summarizes the consensual statements
between the three factors. All three types of
Table 2 Demographics
Characteristic N %total
Age <20 1 3
21–30 18 60
>30 11 37
Ethnicity White 24 80
Mixed 1 3
Asian 4 13
Caribbean 1 3
Marital status Single 5 17
Divorced/Separated 2 7
Married 15 50
Common Law 6 20
Other 2 7
Occupation Health care 4 13
Sales 1 3
Education 4 13
IT 1 3
Community 5 17
Arts 2 7
Administration 3 10
Maintenance 1 3
Housewife 8 27
Legal 1 3
Demographic details of the 30 pregnant women involved in PRiDE
who participated in this study.
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participant were in agreement with that the area
of research is an important one, and that there is
trust in the health-care professionals looking
after them that their decision to take part
bears no relation to the type of care they will
receive. This was highlighted to them during the
consenting process.
Viewpoint 1
‘Helping the future of medicine’: This viewpoint
is to take part because she supports medical
research the future of medicine. These partici-
pants believe that PRiDE is an important study
that will help future generations. Below are
example statements given by the participants.
“Cures and treatments arise when people agree to
be part of medical studies so it is important that I
take part to help provide answers and treatments.
I am part of a healthcare team and understand
how important research is to ﬁnding treatments so
I feel I should help in any way I can.” Participant
L5FYP2ZR is a 25-year-old British nurse.
“[I chose to take part] because there is no risk to
me or my baby, but taking part in this study may
Figure 2 An example of a factor array (depicting viewpoint 1 in this case). A participant that loaded heavily on viewpoint 1
strongly agreed with the statements on the right and disagreed with statements on the left.
Table 3 Correlations
Viewpoints 1 2 3
1 1.00 0.61 0.42
2 0.61 1.00 0.55
3 0.42 0.55 1.00
The mathematical correlation between the viewpoints calculated
using Pearson’s correlation coefficient. Figures are expressed in ratios
with 1 delineating exact correlation and 0 delineating no correlation.
We can see that viewpoints 1 and 2 are 61% correlated, viewpoints 1
and 3 are 42% correlated, and viewpoints 2 and 3 are 55% correlated.
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help.” Participant SENYHCMG is a 28-year-old
British married housewife.
These participants agree to take part for the
greater good, rather than personal gain: they do
not believe that it will get them more attention
from health-care professionals or that their
access to care will be any better. There is also no
evidence of a personal connection to the disease.
“I tend to think about the generation of the future
and the impact society has on them.” Participant
7F0XALGH is a 26-year-old Asian youth worker.
Participants loading on viewpoint 1 were aged
25–39, 67% were British, and 50% were
married. Interestingly, 67% were public sector
workers, with 75% of these working in
health care.
Viewpoint 2
‘My responsibility’: in contrast to viewpoint 1,
viewpoint 2 participants have a personal connec-
tion to diabetes and may feel that it is their
responsibility to help the research to help those
aﬀected in the future. Comparing to viewpoint
1, these participants have a speciﬁc interest
in diabetes, rather than medical research
in general.
Table 4 High- and low-scoring statements
High-scoring statements Low-scoring statements
Viewpoint 1 It might help someone else in the future I might get more attention from health-care professionals
if I take part
I would not take part in the study if there
was any risk to my baby
I know someone who has been affected by diabetes in
pregnancy
I would like to support medical science I did not want to disappoint the person who asked me
It is an important area of research I am scared of declining in case it effects my care later on
The benefits of taking part outweigh the risks I might get better or faster access to care
Viewpoint 2 I know someone who has been affected by
diabetes in pregnancy
I might get more attention from health-care professionals
if I take part
It might help someone else in the future I would prefer to leave it to someone else to take part
I know someone who has been affected by diabetes I am scared of declining in case it effects my care later on
I am interested in finding out the results of this study I might get better or faster access to care
The benefits of taking part outweigh the risks I do not like the time commitment required
Viewpoint 3 I know someone who has been affected by diabetes I would prefer to leave it to someone else to take part
Taking part is the right thing to do I am scared of developing diabetes because of what I
have heard in the media
I do not mind giving a DNA sample The study might be big in the media
The appointments are at the same time as my scans I want to be part of a study that involves a large number
of people
It is an important area of research I want to learn more about the condition
High- and low-scoring statements are presented for each viewpoint. A high-scoring statement appeared at the agree-most end of the exemplary
Q-Sorts for each viewpoint. A low-scoring statement appeared at the disagree-most end. These ideas represent the defining points that make
these viewpoints unique and highlight their similarities.
Table 5 Consensual statements
Statement Viewpoint 1 position Viewpoint 2 position Viewpoint 3 position
It is an important area of research +3 +2 +3
I am scared of declining in case it effects my care later on 3 3 2
I did not want to disappoint the person that asked me 3 3 2
All three types of participant agree that the area of research is an important one, that declining would not affect future care, and that they did not
agree to take part to avoid disappointing the person who asked them.
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“Research is also key to my future so being part of
this study may help doctors to develop a cure for
diabetes sooner than hoped. Research is key to
future developments in medicine and care and I
am more than happy to participate in any study
that will beneﬁt my children/our future genera-
tions in years to come.” Participant 4ZX0Q6UE is
a 34-year-old single administration assistant.
Due to the personal experience, there is a
sense of fear amongst these participants that
they may be aﬀected.
“A friend recently had a baby and she developed
diabetes during pregnancy. Before pregnancy she
was ﬁne and healthy.” Participant GAKHWRZX
is a 25-year-old British common-law warehouse
worker.
“My auntie has severe diabetes that began at preg-
nancy many years ago. She is facing losing her toes
this year. I used to be scared of diabetes but the
amount of information now available is reassur-
ing.” Participant E2ZJS9VF is a 31-year-old
married British housing oﬃcer.
Similar to factor 1 participants, these partici-
pants are not interested in personal beneﬁts of
taking part in the study. Statements involving
personal beneﬁts were ranked low, as seen in
factor 1.
“It doesn’t matter to me if I get more care or not. I
just wanted to help.” Participant CQ0YIHGD is a
29-year-old general assistant.
“I don’t think it is right to take part in a trial to get
better health care.” That’s the wrong reason to do
it. Participant E2ZJS9VF (as above).
Participants loading on viewpoint 2 were also
67% British and aged between 25 and 39. 78%
were married (compared to 50% of viewpoint 1
participants). Once more, a signiﬁcant propor-
tion were public sector workers (56%); however,
only 29% of these worked in health care.
Viewpoint 3
‘No skin oﬀ my nose’: viewpoints in this group
were more diﬃcult to interpret about distinctive
reasons that attracted them to the study; how-
ever, they did not mind taking part because they
did not feel inconvenience by it. Had it been a
more invasive study, they may have opted out.
“The commitment has been manageable and as my
mum had diabetes I thought I might be an interest-
ing candidate for the research. I think if one can
help one should especially if the commitment is
low and manageable, e.g., all extra blood tests etc.
have been taken at the same time as the normal
pregnancy blood tests.” Participant ZN2IRWEY
is a 29-year-old married British housewife.
They lie somewhere between factors 1 and 2,
whereby they may know someone aﬀected by
diabetes and they also think it is an important
area of research, however do not seem to as feel
personally responsible as factor 2 participants,
or as interested in the research as factor 1
participants. They are not particularly drawn
to diabetes, but their participation is not
an inconvenience.
Heavy-loading viewpoint 3 participants were
aged between 29 and 34, all were British, and
50% were married. Once again, the proportion
of health-care workers was more than
expected (50%).
Four statements that factor 1 participants dis-
agreed with and factor 2 participants agreed
with highlight their diﬀering reasons for taking
part as follows:
1. I am scared of developing diabetes because of
what I have heard in the media
2. I think I might be aﬀected by diabetes in my
pregnancy
3. I know someone who has been aﬀected by
diabetes
4. I know someone who has been aﬀected by
diabetes in pregnancy.
It is clear that fear and personal experience
have inﬂuenced the factor 2 participants.
Discussion
We conducted a study using a methodology
ideal for examining subjectivity to elucidate the
opinions of women involved in an observational
trial in those at risk of diabetes in pregnancy.
The majority of the 30 women aged 19–40 were
Caucasian, and either employed in the public
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sector, or were housewives. We found three dis-
tinct opinions as to why pregnant women choose
to participate in research: an interest in helping
medical research advancement, a personal con-
nection to the disease and the lack of
inconvenience. All three groups agreed that it
was an important area of research, beneﬁts out-
weighed risks, and that personal gain did not
inﬂuence their decision.
As highlighted by Lylerly et al.,10 there are a
group of women in whom the fear of contracting
a disease motivates them to take part in
research. Similarly, one group of the women
interviewed by Mohanna et al.,5 who had
declined to take part in a clinical trial had done
so because of a lack of belief that the disease
would aﬀect them. In our study, women who
feared developing diabetes were the women who
knew someone aﬀected by the disease. It is inter-
esting to note that these women agreed to take
part, despite knowing that the PRiDE study
would not help them personally. In fact, no
statements relating to a beneﬁt to personal
health featured in the high-ranking statements
of any groups, unlike previous studies.6,7,10 Also
in contrast to studies who noted a better out-
come for the baby being a strong motivational
factor6,8 and a potential risk being a demotiva-
tor,5,10 our study participants agreed to take
part in the trial knowing that their baby would
not be harmed nor helped. Interestingly, as
demonstrated by Nechuta et al.,11 there was a
preconception amongst the study team that cord
and tissue collection and storage may be unpop-
ular amongst pregnant women and demotivate
them to take part. Our participants across all
three viewpoints were indiﬀerent about this; the
collection and storage of samples did not aﬀect
their decision to participate. We postulate that
including women who declined to take part in
PRiDE would have brought forward this issue.
One weakness of this study is that some par-
ticipants may have found the process of
completing a Q-Sort arduous, and they would
have had to ﬁll a number of other questionnaires
during the same appointment. To avoid the
temptation for the participants to sort state-
ments at random, we chose to have the
questionnaire administered during the 2-h
waiting period at the glucose tolerance test
appointment: a time that the participants were
asked to sit in a waiting room with Minimal dis-
tractions. We hoped that these measures would
ensure participants paid attention to the task.
The fact that there were correlations between
Sorts is reassuring that the participants engaged
in the process.
Another diﬃculty with a Q-Methodology
study is that to create a conclusive Q-Set of
statements, all current opinions on the matter
need to be evaluated. We reviewed all literature
to date, although this was limited; therefore, our
Q-Set may not be as broad and inclusive of all
opinions as we would hope. At the end of the
questionnaire, we included a free-text section for
participants to express any additional views they
held. This did not reveal any further possi-
ble statements.
As evident from the demographics of the
study, a large number of our participants were
Caucasian, married, and either worked in the
public sector or were housewives. This may rep-
resent the type of participant who would agree
to take part in the PRiDE study. It is possible
that housewives are able to be more ﬂexible with
their time and are therefore more open-minded
when being asked to take part in research. Public
sector workers, particularly those in health care,
may be more aware of the need for research in
medical advancement and more eager to help. It
would have been interesting to involve women
who declined to take part in the study, as done
by Mohanna et al.5; however, we decided
against this as some women may have felt har-
assed if they had been asked to complete a
questionnaire on involvement in research having
declined to take part. It may also be true that
participants who consented to take part in the
Q-Study are a group who are already more likely
to want to participate in research.
In conclusion, this study has provided insight
into the ﬁeld of pregnant women participation in
trials. The information can be used in research
development for trials involving this specialist
ª 2016 The Authors. Health Expectations Published by John Wiley & Sons Ltd
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group of patients who diﬀer from usual trial par-
ticipants, because they are not unwell and they
consider their unborn child when consenting to
trials. We have shown that in order for a preg-
nant woman to consider trial participation, the
study should have the potential to make a diﬀer-
ence, be relevant to the participant and be
minimally invasive in terms of time and tests. It
is important to note that these women were
involved in a non-interventional trial and so
their reasons may diﬀer to those in an interven-
tional randomized controlled trial. Further work
should include investigation across socio-
economic groups and ethnicities as well as inves-
tigating the women who have declined
participation to better understand their barriers.
We have shown that Q-Methodology is a
practical way to gain an objective view early on
in a medical trial on what is drawing the partici-
pants to take part. It allows for ﬁne-tuning the
recruitment process to present to potential par-
ticipants the reasons that they may ﬁnd
attractive when making the decision to consent.
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